2008;93(12):4774–9. Nur für den privaten Gebrauch. There was a higher rate of retinopathy events with liraglutide than with placebo, although the difference was not significant. JAMA 2015;314:687-699, 27. Basal insulin and cardiovascular and other outcomes in dysglycemia. In this double-blind trial, we randomly assigned patients with type 2 diabetes and high cardiovascular risk to receive liraglutide or placebo. PubMed  2016a). The frequencies of nonfatal myocardial infarction and nonfatal stroke were lower in the liraglutide group than in the placebo group, although the differences were not significant (Figure 1C and Figure 1D and Table 1). Institute of Medicine. Editorial support, funded by the sponsor, was provided by an independent medical writer under the guidance of the authors. 2016 May 1;213(9):1380-7. Design of the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial. Sensitivity analyses suggested that our findings were robust to baseline adjustment and alternative censoring. Bozkurt L, Göbl CS, Pfligl L, et al. Diabetes. Circ Res 2014;114:1788-1803, 14. Eickhorst A, Brand C, Lang K et al (2015) Die Prävalenzstudie „Kinder in Deutschland KiD 0–3“ zur Erfassung von psychosozialen Belastungen und Frühen Hilfen in Familien mit 0–3jährigen Kindern. Article  Nauck, Prof. Dr. Bernhard (et al.) EN; Menü . Deutschland befindet sich seit 2015 im oberen Drittel auf Platz neun der Rangreihenfolg… The first and last authors wrote the first draft of the manuscript, which was revised and approved by all the authors, who also assume responsibility for the accuracy and completeness of its content and for the decision to submit the manuscript for publication. PubMed Central  The primary composite outcome in the time-to-event analysis was the first occurrence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke. Aber auch ex-plorative Herangehensweisen, wie Assoziations-/ Korrelationsanalysen auf externen Datenbestän-den, fallen in diese Kategorie. Göbl CS, Bozkurt L, Rivic P, et al. From the University of Texas Southwestern Medical Center, Dallas (S.P.M. Schwangerschaftswoche), sollen als Schwangere mit manifestem Diabetes klassifiziert und ebenso behandelt werden. Death from cardiovascular causes occurred in fewer patients in the liraglutide group (219 patients [4.7%]) than in the placebo group (278 [6.0%]) (hazard ratio, 0.78; 95% CI, 0.66 to 0.93; P=0.007) (Figure 1B). Adv Ther 2014;31:1182-1195, 8. ), and St. Josef Hospital, Ruhr University, Bochum (M.A.N.) MitReal-time Analytics sollenaktuelleGescheh-nisse in der operativen Steuerung, zum Beispiel in der Produktion oder dem Online-Wertpapierhan- Wang et al (J Infect Dis 2016; 213:1380-7). Uniform enrollment was projected over the period of 1.5 years. Performance of the OGTT (120 min; 75 g glucose) may already be indicated in the first trimester in some women but is mandatory between 24 and 28 gestational weeks in all pregnant women with previous non-pathological glucose metabolism (Evidence level B). Marso SP, Poulter NR, Nissen SE, et al. PDF | On May 2, 2016, Kathleen Meyer and others published Meyer et al. Ein einziger erhöhter Wert ist für die Diagnose ausreichend und bedarf bereits einer strikten Stoffwechselkontrolle. The major inclusion criteria were the following: an age of 50 years or more with at least one cardiovascular coexisting condition (coronary heart disease, cerebrovascular disease, peripheral vascular disease, chronic kidney disease of stage 3 or greater, or chronic heart failure of New York Heart Association class II or III) or an age of 60 years or more with at least one cardiovascular risk factor, as determined by the investigator (microalbuminuria or proteinuria, hypertension and left ventricular hypertrophy, left ventricular systolic or diastolic dysfunction, or an ankle–brachial index [the ratio of the systolic blood pressure at the ankle to the systolic blood pressure in the arm] of less than 0.9).9 Major exclusion criteria were type 1 diabetes; the use of GLP-1–receptor agonists, dipeptidyl peptidase 4 (DPP-4) inhibitors, pramlintide, or rapid-acting insulin; a familial or personal history of multiple endocrine neoplasia type 2 or medullary thyroid cancer; and the occurrence of an acute coronary or cerebrovascular event within 14 days before screening and randomization. Obstet Gynecol. Wiener klinische Wochenschrift 2016 Apr 9;387(10027):1540-1550. doi: 10.1016/S0140-6736(15)01281-7. Diabetes and pregnancy: an endocrine society clinical practice guideline. Results from a European multicenter randomized trial of physical activity and/or healthy eating to reduce the risk of gestational diabetes mellitus: the DALI lifestyle pilot. Prespecified Cox proportional-hazard regression analyses were performed for subgroups of patients with respect to the primary outcome (first occurrence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke). The primary composite outcome in the time-to-event analysis was the first occurrence of death from cardiovascular causes, nonfatal (including silent) myocardial infarction, or nonfatal stroke. 2011;34(10):2279–84. Among rodents receiving liraglutide, higher rates of thyroid C-cell tumors and hyperplasia have been observed than were observed among control animals.27 In the present trial, no episodes of C-cell hyperplasia or medullary thyroid carcinoma were observed in patients in the liraglutide group. Alle Frauen müssen über ihr (siebenfach erhöhtes relatives) Risiko informiert werden, im weiteren Verlauf einen Typ 2 Diabetes zu entwickeln sowie über mögliche Präventionsmaßnahmen. 2015;15:54. doi:10.1186/s12887-015-0372-1. 31. Cardiovascular actions of incretin-based therapies. 2009(3):CD003395. London: European Medicines Agency, 2012. Expert Opin Drug Saf 2015;14:171-180, 24. Frauen, die die Kriterien eines manifesten Diabetes bereits in der Frühschwangerschaft erfüllen (Nüchternplasmaglukose > 126 mg/dl, Spontanglukosemessung über 200 mg/dl oder HbA1c > 6,5 % vor der 20. Association between sitagliptin use and heart failure hospitalization and related outcomes in type 2 diabetes mellitus. Mohammed bin Salman al-Saud (arabisch محمد بن سلمان بن عبد العزيز آل سعود, DMG Muḥammad b. Salmān b. PubMed  The percentages of patients with a first primary outcome between the randomization date and the date of last follow-up are shown. Notes. B. Fischer-Tropsch-Diesel) sowie die schnelle und langsame Pyrolyse (d. h. Bioöl- und Holzkohleerzeugung). J Environ Sci Health C Environ Carcinog Ecotoxicol Rev, Case Records of the Massachusetts General Hospital, The FDA’s Experience with Covid-19 Antibody Tests, Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma, Caring for the Caregivers — Covid-19 Vaccination for Essential Members of the Health Care Team, Escaping Catch-22 — Overcoming Covid Vaccine Hesitancy, Case 4-2021: A 70-Year-Old Woman with Dyspnea on Exertion and Abnormal Findings on Chest Imaging, Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection, Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis, for the LEADER Steering Committee on behalf of the LEADER Trial Investigators. A sensitivity analysis of data for patients with an eGFR of less than 60 ml per minute per 1.73 m2 did not support a clinically meaningful interaction (Table S3 in the Supplementary Appendix). In addition, prespecified sensitivity analyses were conducted (see the protocol). Die Verantwortung für den Inhalt dieser Veröffentlichung liegt beiden Autorinnen und Autoren. Also, because our trial recruited a population of patients who were at high risk for cardiovascular events and who had a baseline glycated hemoglobin level of 7% or more, the observed benefits and risks may not apply to patients at lower risk. (2016) Child Adolesc. doi:10.1210/jc.2014-4055. Frauen, die die Kriterien eines manifesten Diabetes bereits in der Frühschwangerschaft erfüllen (Nüchternplasmaglukose > 126 mg/dl, … 6. Altman DG, Andersen PK. In the present trial, there were fewer hospitalizations for heart failure among patients in the liraglutide group than among those in the placebo group, although the difference was not significant. Davies MJ, Bergenstal R, Bode B, et al. (2016). Acute pancreatitis occurred in 18 patients in the liraglutide group and in 23 in the placebo group. CVD denotes cardiovascular disease. Safety of insulin analogs during pregnancy: a meta-analysis. NEW! 2008;31(8):1668–9. N Engl J Med 2013;369:1327-1335, 21. Ussher JR, Drucker DJ. (et al.) Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. There were 1.5 episodes of pancreatitis per 1000 patient-years of observation in both regimens combined, and there were numerically fewer acute or chronic pancreatitis events with liraglutide than with placebo. doi:10.1007/s00125-012-2726-7. doi:10.1001/jamapediatrics.2015.74. © Waxmann Verlag GmbH. Diabetes Care 2016;39:Suppl 1:S1-2. Patients with type 2 diabetes who were at high risk for cardiovascular disease were randomly assigned, in a 1:1 ratio, to receive liraglutide or placebo. This article was published on June 13, 2016, at NEJM.org. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. doi:10.1016/S0140-6736(09)60515-8. 2016 haben wir 123 Geflüchtete aus den wichtigsten Herkunftsländern der Fluchtmigration und 26Exper- ten aus der Flüchtlingsarbeit befragt. doi:10.1097/AOG.0b013e318220e18f. Sinai Hospital, University of Toronto, Toronto (B.Z. J Clin Endocrinol Metab. Bei Normalbefund soll der OGTT alle 2 Jahre wiederholt werden (Evidenzklasse B). BMC Pediatr. S3 in the Supplementary Appendix). The definitions that were used for the clinical events and the members of the committee are listed in the Supplementary Appendix. Subgroup analyses are shown in Figure 2. There were fewer add-on therapies for diabetes medications, lipid-lowering medications, and diuretics in patients in the liraglutide group than in those in the placebo group. Alogliptin after acute coronary syndrome in patients with type 2 diabetes. Guideline on clinical investigation of medicinal products in the treatment or prevention of diabetes mellitus. This diagnostic approach was recently also recommended by the WHO. A total of 9340 patients underwent randomization from September 2010 through April 2012; 4668 patients were randomly assigned to receive liraglutide and 4672 to receive placebo. 2016, S. 279). CAS  2011 [cited 2015]: Available from: http://www.deutsche-diabetes-gesellschaft.de/fileadmin/Redakteur/Leitlinien/Evidenzbasierte_Leitlinien/Gestationsdiabetes_EbLL_Endfassung_2011_08_11_.pdf. BMJ 1999;319:1492-1495, 11. Zusätzlich wird auf die thermo-chemische Umwandlung in hydrothermaler Atmosphäre (z. BMJ Open 2013;3, 9. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Vorschau Kapitel kaufen 26,70 € Bildungstransmission in Migrantenfamilien. M. Lechleitner hat von folgenden Unternehmen, die auch fördernde Mitglieder der ÖDG sind, Honorare erhalten: AstraZeneca, Bristol-Myers Squibb, Germania Pharmazeutika, GlaxoSmithKline Pharma, Eli Lilly, Medtronic, Merck Sharp & Dome, Novartis, Novo Nordisk, Pfizer, Sanofi-Aventis, Takeda. doi:10.1210/jc.2013-2465. Peer-reviewed journal featuring in-depth articles to accelerate the transformation of health care delivery. P values signify tests of homogeneity for between-group differences with no adjustment for multiple testing. Tax calculation will be finalised during checkout. (2016) definieren eine Blockchain als ein elektronisches Register für di-gitale Datensätze, Ereignisse oder Transaktionen, die durch die Teilnehmer eines ver-teilten Rechnernetzes verwaltet werden. It is uncertain whether this finding relates to the direct effects of liraglutide on kidney function.21,22, More patients in the liraglutide group than in the placebo group permanently discontinued the trial regimen owing to adverse events (difference, 2.2 percentage points). 2016. Lange C, Starker A et al. „Mit der PISA-Studie 2015 bestätigt sich das positive Bild der Ergebnisse zur Lesekompetenz aus der PISA-Erhebung im Jahr 2012, bei welcher die durchschnittliche Lesekompetenz der Fünfzehnjährigen in Deutschland erstmals über dem Durchschnitt der OECD-Staaten lag“, so das Fazit der Herausgeber von PISA (Reiss et al. (dip) ist ein gemeinnütziges Institut an der Katholischen Hochschule Nordrhein-Westfalen (KatHO NRW) in Köln. The primary and exploratory analyses for the outcomes in the time-to-event analyses were based on a Cox proportional-hazards model with treatment as a covariate. Camelo Castillo W, Boggess K, Sturmer T, et al. The mean levels of serum amylase and lipase were higher in the liraglutide group than in the placebo group (Fig. In conclusion, among patients with type 2 diabetes who were at high risk for cardiovascular events while they were taking standard therapy, those in the liraglutide group had lower rates of cardiovascular events and death from any cause than did those in the placebo group. Epub 2015 Dec 19. Gestationsdiabetes (GDM) wird als Glukosetoleranzstörung definiert, die erstmals in der Schwangerschaft entdeckt wird. The primary composite outcome occurred in fewer patients in the liraglutide group (608 of 4668 patients [13.0%]) than in the placebo group (694 of 4672 [14.9%]) (hazard ratio, 0.87; 95% confidence interval [CI], 0.78 to 0.97; P<0.001 for noninferiority; P=0.01 for superiority) (Table 1 and Figure 1A). A total of 96.8% of the patients completed a final visit, died, or had a primary outcome. Und zwar bekomme ich immer ein Komma zu viel beim Literaturverzeichnis, nämlich wird vor dem & noch ein Komma gesetzt, was natürlich überflüssig ist. 1. Correspondence to Patients were scheduled for follow-up visits at months 1, 3, and 6 and every 6 months thereafter. PubMed  Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. doi:10.2337/dc15-0360. The primary composite outcome in the time-to-event analysis was the first occurrence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke. Hallo :) Ich habe ein Problem mit den APA-Einstellungen zum Zitieren bei Word 2016. Is early postpartum HbA1c an appropriate risk predictor after pregnancy with gestational diabetes mellitus? 2015;38(9):1650–6. The median daily dose of liraglutide was 1.78 mg (interquartile range, 1.54 to 1.79), including periods during which the patients did not receive liraglutide. N Engl J Med 2013;369:1317-1326, 20. Maternal and fetal monitoring is required in order to minimize maternal and fetal/neonatal morbidity and perinatal mortality. doi:10.1210/jc.2007-2301. 2013;98(11):4227–49. ); Friedrich Alexander University of Erlangen, Erlangen (J.F.E.M. PubMed  Ijas H, Vaarasmaki M, Morin-Papunen L, et al. S4 in the Supplementary Appendix. Schwangerschaftswoche vorgeschrieben (Evidenzklasse B). Benefits and risks of oral diabetes agents compared with insulin in women with gestational diabetes: a systematic review. Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes. ); Novo Nordisk, Bagsvaerd, Denmark (K.B.-F., P.K., L.S.R., M.S. ten Deutschen auf jeden Fall (Horkheimer et al., 1936). After delivery all women with GDM have to be reevaluated as to their glucose tolerance by a 75 g OGTT (WHO criteria) 6–12 weeks postpartum and every 2 years in case of normal glucose tolerance (Evidence level B). N Engl J Med 2015;373:232-242, 18. This result appears to have been driven by gastrointestinal disorders in the liraglutide group. in einem längeren Bericht veröffentlicht (Brücker et al. The demographic and clinical characteristics of the patients were similar in the two groups (Table S2 in the Supplementary Appendix). Balsells M, Garcia-Patterson A, Sola I, et al. Lancet 2005;366:1279-1289, 16. Rowan JA, Rush EC, Obolonkin V, et al. BMJ. N Engl J Med. Anke Hanft, Katrin Brinkmann, Stefanie Kretschmer, Annika Maschwitz, Joachim Stöter Nat Rev Nephrol 2014;10:88-103, 22. doi:10.1007/s00404-015-3692-3. A complete list of the investigators in the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) trial is provided in the Supplementary Appendix, available at NEJM.org. doi:10.2337/db08-1112. The incidence of a composite outcome of renal or retinal microvascular events was lower in the liraglutide group than in the placebo group (hazard ratio, 0.84; 95% CI, 0.73 to 0.97; P=0.02), a difference that was driven by a lower rate of nephropathy events in the liraglutide group (1.5 vs. 1.9 events per 100 patient-years of observation; hazard ratio, 0.78; 95% CI, 0.67 to 0.92; P=0.003) (Table 1). No other potential conflict of interest relevant to this article was reported. Condos et al. Cyber-Physische Systeme sind durch den Austausch digitaler Daten miteinander vernetzt und können sich selbst steuern (Ganschar et al., 2013). 2016 Jun 30;166(1):21-45. doi: 10.1016/j.cell.2016.06.028. The glycated hemoglobin level was measured at randomization, at month 3, and then every 6 months thereafter. Two-sided P values are presented throughout. The number of patients who would need to be treated to prevent one event in 3 years was 66 in the analysis of the primary outcome and 98 in the analysis of death from any cause.10 There has been concern about the risk of hospitalization for heart failure with various agents that have been used to treat diabetes mellitus, including DPP-4 inhibitors.11 In the present trial, there were fewer hospitalizations for heart failure among patients in the liraglutide group than among those in the placebo group, although the difference was not significant. Ein Screening auf unerkannten Typ 2 Diabetes bei der ersten pränatalen Kontrolle wird besonders bei Frauen mit hohem Risiko (Anamnese eines GDM oder Prädiabetes; Fehlbildungen, Totgeburt, wiederholte Aborte oder Geburtsgewicht über 4500 g in früheren Schwangerschaften; Adipositas, metabolisches Syndrom, Alter über 45 Jahre, bei Gefäßerkrankungen, Auftreten von Diabetessymptomen wie Glukosurie) empfohlen (Evidenzklasse B). Prespecified exploratory outcomes included an expanded composite cardiovascular outcome (death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, coronary revascularization, or hospitalization for unstable angina pectoris or heart failure), death from any cause, a composite renal and retinal microvascular outcome (nephropathy [defined as the new onset of macroalbuminuria or a doubling of the serum creatinine level and an eGFR of ≤45 ml per minute per 1.73 m2, the need for continuous renal-replacement therapy, or death from renal disease] and retinopathy [defined as the need for retinal photocoagulation or treatment with intravitreal agents, vitreous hemorrhage, or the onset of diabetes-related blindness]), neoplasms, and pancreatitis — all of which were adjudicated in a blinded fashion by an external, independent event-adjudication committee. Robinson LE, Holt TA, Rees K, Randeva HS, O’Hare JP. Ramón y Cajal s/n, 03550 San Juan de Alicante, Spain. Of the 9340 patients, the majority (7598 [81.3%]) had established cardiovascular disease (6764 patients [72.4%]), chronic kidney disease of stage 3 or higher (2307 [24.7%]), or both (1473 [15.8%]). Google Scholar. B. hydrothermale Karbonisierung) eingegangen. GDM ist mit einer erhöhten feto-maternalen Morbidität sowie Langzeitkomplikationen bei Mutter und Kind assoziiert. Metzger BE, Gabbe SG, Persson B, et al. The protocol for the treatment of risk factors and the concomitant use of medications was developed by a global expert panel (Table S1 in the Supplementary Appendix, available at NEJM.org). The primary hypothesis was that liraglutide would be noninferior to placebo with regard to the primary outcome, with a margin of 1.30 for the upper boundary of the 95% confidence interval of the hazard ratio.